124P Surufatinib plus toripalimab combined with etoposide (E) and cisplatin (P) in patients (pts) with advanced naive small cell lung cancer (SCLC): Updated results of a phase Ib/II trial
| Autor: | Fang, W.F., Yang, Y., Huang, Y., Zhao, Y., Zhang, Y., Zhou, T., Chen, G., Zhao, S., Ma, Y., Hong, S., Zhao, H., Zhang, L. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|